These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

266 related items for PubMed ID: 18388031

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42. The role of cilostazol in the treatment of intermittent claudication.
    Barnett AH, Bradbury AW, Brittenden J, Crichton B, Donnelly R, Homer-Vanniasinkam S, Mikhailidis DP, Stansby G.
    Curr Med Res Opin; 2004 Oct; 20(10):1661-70. PubMed ID: 15462700
    [Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44. Cilostazol.
    Sorkin EM, Markham A.
    Drugs Aging; 1999 Jan; 14(1):63-71; discussion 72-3. PubMed ID: 10069409
    [Abstract] [Full Text] [Related]

  • 45. Cilostazol: a review of its use in intermittent claudication.
    Chapman TM, Goa KL.
    Am J Cardiovasc Drugs; 2003 Jan; 3(2):117-38. PubMed ID: 14727939
    [Abstract] [Full Text] [Related]

  • 46. Clinical manifestation of atherosclerotic peripheral arterial disease and the role of cilostazol in treatment of intermittent claudication.
    Grouse JR, Allan MC, Elam MB.
    J Clin Pharmacol; 2002 Dec; 42(12):1291-8. PubMed ID: 12463722
    [Abstract] [Full Text] [Related]

  • 47. Effect of cilostazol in patients with intermittent claudication: a randomized, double-blind, placebo-controlled study.
    Strandness DE, Dalman RL, Panian S, Rendell MS, Comp PC, Zhang P, Forbes WP.
    Vasc Endovascular Surg; 2002 Dec; 36(2):83-91. PubMed ID: 11951094
    [Abstract] [Full Text] [Related]

  • 48. Systematic review of the efficacy of cilostazol, naftidrofuryl oxalate and pentoxifylline for the treatment of intermittent claudication (Br J Surg 2012; 99: 1630-1638).
    Roset PN.
    Br J Surg; 2013 Dec; 100(13):1838. PubMed ID: 24227374
    [No Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. Treatment with pharmacological agents in peripheral arterial disease patients does not result in biomechanical gait changes.
    Huisinga JM, Pipinos II, Stergiou N, Johanning JM.
    J Appl Biomech; 2010 Aug; 26(3):341-8. PubMed ID: 20841626
    [Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53. Vascular function in patients with lower extremity peripheral arterial disease: a comparison of functions in upper and lower extremities.
    Sanada H, Higashi Y, Goto C, Chayama K, Yoshizumi M, Sueda T.
    Atherosclerosis; 2005 Jan; 178(1):179-85. PubMed ID: 15585216
    [Abstract] [Full Text] [Related]

  • 54. Effects of oral beraprost sodium, a prostaglandin I2 analogue, on endothelium dependent vasodilatation in the forearm of patients with coronary artery disease.
    Ohata S, Ishibashi Y, Shimada T, Takahashi N, Sugamori T, Sakane T, Hirano Y, Oyake N, Murakami Y, Higami T.
    Clin Exp Pharmacol Physiol; 2006 Apr; 33(4):381-7. PubMed ID: 16620305
    [Abstract] [Full Text] [Related]

  • 55. Analysis of the cilostazol safety database.
    Pratt CM.
    Am J Cardiol; 2001 Jun 28; 87(12A):28D-33D. PubMed ID: 11434897
    [Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57. Short-range intermittent claudication and rest pain: microcirculatory effects of pentoxifylline in a randomized, controlled trial.
    Incandela L, De Sanctis MT, Cesarone MR, Belcaro G, Nicolaides AN, Geroulakos G, Ramaswami G.
    Angiology; 2002 Jun 28; 53 Suppl 1():S27-30. PubMed ID: 11865832
    [Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. Intermittent claudication: effective medical management of a common circulatory problem.
    Beebe HG.
    Am J Cardiol; 2001 Jun 28; 87(12A):14D-18D. PubMed ID: 11434895
    [Abstract] [Full Text] [Related]

  • 60. Treatment of intermittent claudication with physical training, smoking cessation, pentoxifylline, or nafronyl: a meta-analysis.
    Girolami B, Bernardi E, Prins MH, Ten Cate JW, Hettiarachchi R, Prandoni P, Girolami A, Büller HR.
    Arch Intern Med; 1999 Feb 22; 159(4):337-45. PubMed ID: 10030306
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.